Acceleron Investigative Site — Detroit, Michigan

Acceleron Investigative Site is a clinical research site located in Detroit, Michigan, United States.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Acceleron Investigative Site has participated in 1 clinical trials.

Therapeutic areas: Squamous Cell Carcinoma of the Head and Neck.

Sponsors: Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Acceleron Investigative Site?

Acceleron Investigative Site has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Acceleron Investigative Site conducted?

Acceleron Investigative Site has 1 clinical trials on record. Their work covers Squamous Cell Carcinoma of the Head and Neck.

Is Acceleron Investigative Site accredited by Crixeo Health?

Acceleron Investigative Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Acceleron Investigative Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.